125 related articles for article (PubMed ID: 25574525)
1. A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling.
Deng Z; Yu L; Cao W; Zheng W; Chen T
Chem Commun (Camb); 2015 Feb; 51(13):2637-40. PubMed ID: 25574525
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.
Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ
Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456
[TBL] [Abstract][Full Text] [Related]
4. Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways.
Huang SH; Wu LW; Huang AC; Yu CC; Lien JC; Huang YP; Yang JS; Yang JH; Hsiao YP; Wood WG; Yu CS; Chung JG
J Agric Food Chem; 2012 Jan; 60(2):665-75. PubMed ID: 22148415
[TBL] [Abstract][Full Text] [Related]
5. Rational Design of Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation.
Deng Z; Yu L; Cao W; Zheng W; Chen T
ChemMedChem; 2015 Jun; 10(6):991-8. PubMed ID: 25914192
[TBL] [Abstract][Full Text] [Related]
6. Microwave-assisted synthesis of arene ruthenium(II) complexes that induce S-phase arrest in cancer cells by DNA damage-mediated p53 phosphorylation.
Wu Q; Fan C; Chen T; Liu C; Mei W; Chen S; Wang B; Chen Y; Zheng W
Eur J Med Chem; 2013 May; 63():57-63. PubMed ID: 23455057
[TBL] [Abstract][Full Text] [Related]
7. A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells.
Silva VR; Corrêa RS; Santos LS; Soares MBP; Batista AA; Bezerra DP
Sci Rep; 2018 Jan; 8(1):288. PubMed ID: 29321581
[TBL] [Abstract][Full Text] [Related]
8. DNA-binding, photocleavage, cytotoxicity in vitro, apoptosis and cell cycle arrest studies of symmetric ruthenium(II) complexes.
Xie YY; Huang HL; Yao JH; Lin GJ; Jiang GB; Liu YJ
Eur J Med Chem; 2013 May; 63():603-10. PubMed ID: 23567948
[TBL] [Abstract][Full Text] [Related]
9. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
[TBL] [Abstract][Full Text] [Related]
10. Triphenylstannyl((arylimino)methyl)benzoates with selective potency that induce G1 and G2/M cell cycle arrest and trigger apoptosis via ROS in human cervical cancer cells.
Basu Baul TS; Longkumer I; Duthie A; Singh P; Koch B; Guedes da Silva MFC
Dalton Trans; 2018 Feb; 47(6):1993-2008. PubMed ID: 29345708
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity studies of a ruthenium(II) polypyridyl complex against human hepatocellular (BEL-7402) cells.
Li W; Han BJ; Yao JH; Jiang GB; Lin GJ; Xie YY; Huang HL; Liu YJ
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():127-34. PubMed ID: 26037497
[TBL] [Abstract][Full Text] [Related]
12. DNA binding, cytotoxicity, and apoptotic-inducing activity of ruthenium(II) polypyridyl complex.
Zhang P; Chen J; Liang Y
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):440-9. PubMed ID: 20705582
[TBL] [Abstract][Full Text] [Related]
13. Effect of radiation on cytotoxicity, apoptosis and cell cycle arrest of human osteosarcoma MG-63 induced by a ruthenium(II) complex.
Liu SH; Zhao JH; Deng KK; Wu Y; Zhu JW; Liu QH; Xu HH; Wu HF; Li XY; Wang JW; Guo QF
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 140():202-9. PubMed ID: 25594209
[TBL] [Abstract][Full Text] [Related]
14. The novel ruthenium-gamma-linolenic complex [Ru(2)(aGLA)(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro.
Ribeiro G; Benadiba M; de Oliveira Silva D; Colquhoun A
Cell Biochem Funct; 2010 Jan; 28(1):15-23. PubMed ID: 19927275
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Activity Studies of Ruthenium(II) Complex Toward Human Osteosarcoma HOS Cells.
Zhu JW; Liu SH; Zhang GQ; Xu HH; Wang YX; Wu Y; Liu YM; Wang Y; Liang JB; Guo QF
J Membr Biol; 2016 Aug; 249(4):483-92. PubMed ID: 27007877
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways.
Xie Q; Zhou Y; Lan G; Yang L; Zheng W; Liang Y; Chen T
Biochem Biophys Res Commun; 2014 Jun; 449(1):88-93. PubMed ID: 24813998
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide increases the sensitivity of 786-0 renal carcinoma cells to radiotherapy.
Su Y; Wang X; Xu W; Xue L; He C; Yang D; An R
Cancer Invest; 2012 Feb; 30(2):114-8. PubMed ID: 22149353
[TBL] [Abstract][Full Text] [Related]
19. Probing the cell death signaling pathway of HepG2 cell line induced by copper-1,10-phenanthroline complex.
Wu J; Chen W; Yin Y; Zheng Z; Zou G
Biometals; 2014 Jun; 27(3):445-58. PubMed ID: 24638265
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, visible light photocleavage, antiproliferative and cellular uptake properties of ruthenium complex [Ru(phen)2(mitatp)]2+.
Yu HJ; Chen Y; Yu L; Hao ZF; Zhou LH
Eur J Med Chem; 2012 Sep; 55():146-54. PubMed ID: 22841281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
